Search

Your search keyword '"Bagga, Arvind"' showing total 55 results

Search Constraints

Start Over You searched for: Author "Bagga, Arvind" Remove constraint Author: "Bagga, Arvind" Database Supplemental Index Remove constraint Database: Supplemental Index
55 results on '"Bagga, Arvind"'

Search Results

1. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

2. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

3. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome

4. Haemolytic uraemic syndrome

5. A Century With Craniopagus Twin Separation Surgeries: Nihilism to Optimism.

6. A Century With Craniopagus Twin Separation Surgeries: Nihilism to Optimism

7. A Core Outcome Set for Trials in Glomerular Disease

8. KM55 in the Evaluation of IgA-Containing Glomerular Diseases

9. IgA Nephropathy and Atypical Anti-GBM Disease: A Rare Dual Pathology in a Pediatric Rapidly Progressive Glomerulonephritis

11. Ultrasound Imaging of Renal Cysts in Children

12. Establishing core outcome domains in pediatric kidney disease: report of the Standardized Outcomes in Nephrology—Children and Adolescents (SONG-KIDS) consensus workshops

13. Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy

14. Prescribing peritoneal dialysis for high-quality care in children

15. Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes

16. An international, multi-center study evaluated rituximab therapy in childhood steroid-resistant nephrotic syndrome.

17. Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements

22. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial

23. Management of steroid-resistant nephrotic syndrome in children and adolescents

24. HUS and TTP: traversing the disease and the age spectrum.

26. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome

28. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome

29. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

31. HUS and TTP: traversing the disease and the age spectrum

32. Abstract 14703: Short Term Safety and Efficacy of Escalating Doses of Atorvastatin for Dyslipidemia in Children With Predialysis Chronic Kidney Disease Stage 2-5

33. Anti-complement-factor H-associated glomerulopathies

37. Management of lupus nephritis.

38. Efficacy and safety of the Angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years.

40. Acute kidney injury: an increasing global concern

42. Rituximab therapy in nephrotic syndrome: implications for patients' management

43. The contrasting characteristics of acute kidney injury in developed and developing countries

44. Improving Outcomes from Acute Kidney Injury (AKI): Report on an Initiative

45. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome

47. Hemolytic uremic syndrome in children in northern India

48. Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome

49. Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease

Catalog

Books, media, physical & digital resources